72 related articles for article (PubMed ID: 24891117)
1. CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKT.
Yu W; Wang J; Ma L; Tang X; Qiao Y; Pan Q; Yu Y; Sun F
Oncol Rep; 2014 Aug; 32(2):677-83. PubMed ID: 24891117
[TBL] [Abstract][Full Text] [Related]
2. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells.
Tang X; Chen X; Xu Y; Qiao Y; Zhang X; Wang Y; Guan Y; Sun F; Wang J
Cell Signal; 2015 Sep; 27(9):1694-702. PubMed ID: 26004137
[TBL] [Abstract][Full Text] [Related]
3. Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.
Ma L; Wang J; Lin J; Pan Q; Yu Y; Sun F
J Biol Chem; 2014 Mar; 289(10):6921-6933. PubMed ID: 24482231
[TBL] [Abstract][Full Text] [Related]
4. 20-Hydroxyecdysone activates Forkhead box O to promote proteolysis during Helicoverpa armigera molting.
Cai MJ; Zhao WL; Jing YP; Song Q; Zhang XQ; Wang JX; Zhao XF
Development; 2016 Mar; 143(6):1005-15. PubMed ID: 26893349
[TBL] [Abstract][Full Text] [Related]
5. Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt.
Essafi A; Gomes AR; Pomeranz KM; Zwolinska AK; Varshochi R; McGovern UB; Lam EW
Methods Mol Biol; 2009; 462():201-11. PubMed ID: 19160671
[TBL] [Abstract][Full Text] [Related]
6. CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis.
Fritz RD; Varga Z; Radziwill G
Oncogene; 2010 Jun; 29(24):3575-82. PubMed ID: 20383191
[TBL] [Abstract][Full Text] [Related]
7. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
8. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.
Yamagata K; Daitoku H; Takahashi Y; Namiki K; Hisatake K; Kako K; Mukai H; Kasuya Y; Fukamizu A
Mol Cell; 2008 Oct; 32(2):221-31. PubMed ID: 18951090
[TBL] [Abstract][Full Text] [Related]
9. FoxO proteins: regulation and molecular targets in liver cancer.
Carbajo-Pescador S; Mauriz JL; García-Palomo A; González-Gallego J
Curr Med Chem; 2014 Apr; 21(10):1231-46. PubMed ID: 24372208
[TBL] [Abstract][Full Text] [Related]
10. Angiomotin-like 2 interacts with and negatively regulates AKT.
Han H; Yang B; Wang W
Oncogene; 2017 Aug; 36(32):4662-4669. PubMed ID: 28368415
[TBL] [Abstract][Full Text] [Related]
11. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A; Matysiak W; Motyl T
Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
[TBL] [Abstract][Full Text] [Related]
12. P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells.
Hu H; Li Z; Chen J; Wang D; Ma J; Wang W; Li J; Wu H; Li L; Wu M; Qian Q; Chen J; Su C
Gut; 2011 May; 60(5):710-21. PubMed ID: 20971978
[TBL] [Abstract][Full Text] [Related]
13. Regulation of FOXO protein stability via ubiquitination and proteasome degradation.
Huang H; Tindall DJ
Biochim Biophys Acta; 2011 Nov; 1813(11):1961-4. PubMed ID: 21238503
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
[TBL] [Abstract][Full Text] [Related]
15. CNK1 and other scaffolds for Akt/FoxO signaling.
Fritz RD; Radziwill G
Biochim Biophys Acta; 2011 Nov; 1813(11):1971-7. PubMed ID: 21320536
[TBL] [Abstract][Full Text] [Related]
16. Cluster of differentiation 166 (CD166) regulates cluster of differentiation (CD44) via NF-κB in liver cancer cell line Bel-7402.
Ma L; Pan Q; Sun F; Yu Y; Wang J
Biochem Biophys Res Commun; 2014 Aug; 451(2):334-8. PubMed ID: 25094049
[TBL] [Abstract][Full Text] [Related]
17. CD166 and regulation of hematopoiesis.
Chitteti BR; Bethel M; Kacena MA; Srour EF
Curr Opin Hematol; 2013 Jul; 20(4):273-80. PubMed ID: 23615053
[TBL] [Abstract][Full Text] [Related]
18. ILT3.Fc-CD166 Interaction Induces Inactivation of p70 S6 Kinase and Inhibits Tumor Cell Growth.
Xu Z; Chang CC; Li M; Zhang QY; Vasilescu EM; D'Agati V; Floratos A; Vlad G; Suciu-Foca N
J Immunol; 2018 Feb; 200(3):1207-1219. PubMed ID: 29263213
[TBL] [Abstract][Full Text] [Related]
19. Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis.
Hooker RA; Chitteti BR; Egan PH; Cheng YH; Himes ER; Meijome T; Srour EF; Fuchs RK; Kacena MA
J Musculoskelet Neuronal Interact; 2015 Mar; 15(1):83-94. PubMed ID: 25730656
[TBL] [Abstract][Full Text] [Related]
20. Bimodal regulation of FoxO3 by AKT and 14-3-3.
Dobson M; Ramakrishnan G; Ma S; Kaplun L; Balan V; Fridman R; Tzivion G
Biochim Biophys Acta; 2011 Aug; 1813(8):1453-64. PubMed ID: 21621563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
